These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22633780)

  • 21. Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: comparison with C-reactive protein.
    Nishida H; Horio T; Suzuki Y; Iwashima Y; Tokudome T; Yoshihara F; Nakamura S; Kawano Y
    Cytokine; 2011 Mar; 53(3):342-6. PubMed ID: 21190868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum gamma-glutamyltransferase as a risk factor for general cardiovascular disease prediction in Koreans.
    Kim KM; Kim BT; Lee DJ; Park SB; Joo NS; Kim KN
    J Investig Med; 2012 Dec; 60(8):1199-203. PubMed ID: 23138005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the Cardiovascular Health Study.
    Walston JD; Fallin MD; Cushman M; Lange L; Psaty B; Jenny N; Browner W; Tracy R; Durda P; Reiner A
    Hum Genet; 2007 Dec; 122(5):485-94. PubMed ID: 17851695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-reactive protein and cardiovascular disease: are we looking in the right direction?
    Hashimoto J; O'Rourke MF
    J Hypertens; 2006 Oct; 24(10):2115. PubMed ID: 16957575
    [No Abstract]   [Full Text] [Related]  

  • 25. C-reactive protein for cardiovascular risk assessment.
    Kholeif MA
    Diabetes Care; 2005 Jul; 28(7):1833-4. PubMed ID: 15983350
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiovascular risk in South Asians.
    Ramaraj R; Chellappa P
    Postgrad Med J; 2008 Oct; 84(996):518-23. PubMed ID: 19017836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein and cardiovascular disease risk: still an unknown quantity?
    Davey Smith G; Timpson N; Lawlor DA
    Ann Intern Med; 2006 Jul; 145(1):70-2. PubMed ID: 16818931
    [No Abstract]   [Full Text] [Related]  

  • 28. C-reactive protein, inflammation, and cardiovascular disease: clinical update.
    Ridker PM
    Tex Heart Inst J; 2005; 32(3):384-6. PubMed ID: 16392225
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome.
    Devaraj S; Valleggi S; Siegel D; Jialal I
    Curr Atheroscler Rep; 2010 Mar; 12(2):110-8. PubMed ID: 20425246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-reactive protein and cardiovascular risk in the Framingham Study.
    Ridker P; Rifai N; Koenig W; Blumenthal RS
    Arch Intern Med; 2006 Jun; 166(12):1327-8; author reply 1328. PubMed ID: 16801524
    [No Abstract]   [Full Text] [Related]  

  • 31. C-reactive protein and cardiovascular disease: differences between humans and mice.
    Jeppesen J; Asferg C
    Hypertension; 2010 Jul; 56(1):e15; author reply e16. PubMed ID: 20479326
    [No Abstract]   [Full Text] [Related]  

  • 32. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease.
    Ridker PM; Haughie P
    J Investig Med; 1998 Oct; 46(8):391-5. PubMed ID: 9805425
    [No Abstract]   [Full Text] [Related]  

  • 33. C-reactive protein and the metabolic syndrome: useful addition to the cardiovascular risk profile?
    Szmitko PE; Verma S
    J Cardiometab Syndr; 2006; 1(1):66-9; quiz 70-1. PubMed ID: 17675894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Race and gender differences in C-reactive protein levels.
    Khera A; McGuire DK; Murphy SA; Stanek HG; Das SR; Vongpatanasin W; Wians FH; Grundy SM; de Lemos JA
    J Am Coll Cardiol; 2005 Aug; 46(3):464-9. PubMed ID: 16053959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events.
    Blake GJ; Ridker PM
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1512-3. PubMed ID: 12377722
    [No Abstract]   [Full Text] [Related]  

  • 36. Diabetes and associated complications in the South Asian population.
    Shah A; Kanaya AM
    Curr Cardiol Rep; 2014 May; 16(5):476. PubMed ID: 24643902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adipokine serum concentrations, anthropometric measurements and socio-economic status in two ethnic groups with different prevalence levels for cardiovascular diseases and type 2 diabetes.
    Waisberg R; Paiker JE; Crowther NJ
    Horm Metab Res; 2011 Aug; 43(9):660-6. PubMed ID: 21823063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variation in C-reactive protein in ethnic Chinese population in Taiwan.
    Huang CC; Chung CM; Leu HB; Lin TH; Hung SI; Wu TC; Huang PH; Lin SJ; Pan WH; Chen JW
    Eur J Clin Invest; 2013 May; 43(5):449-56. PubMed ID: 23496329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of C-reactive protein in the assessment of cardiovascular risk.
    Jialal I; Devaraj S
    Am J Cardiol; 2003 Jan; 91(2):200-2. PubMed ID: 12521635
    [No Abstract]   [Full Text] [Related]  

  • 40. C-reactive protein and cardiovascular disease: weighing the evidence.
    Lowe GD; Pepys MB
    Curr Atheroscler Rep; 2006 Sep; 8(5):421-8. PubMed ID: 16901413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.